Health Care & Life Sciences » Pharmaceuticals | Shanghai Shyndec Pharmaceutical Co. Ltd.

Shanghai Shyndec Pharmaceutical Co. Ltd. A | Balance Sheet

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
433
366
422
1,743
2,456
3,860
Total Accounts Receivable
425
451
625
2,542
2,353
2,090
Inventories
511
771
772
1,810
1,919
2,315
Other Current Assets
93
95
75
242
193
204
Total Current Assets
1,461
1,684
1,895
6,337
6,920
8,470
Net Property, Plant & Equipment
1,480
1,831
1,893
7,283
6,774
6,463
Total Investments and Advances
7
7
11
99
165
277
Long-Term Note Receivable
-
6
-
-
1
-
Intangible Assets
199
289
320
1,209
1,171
570
Other Assets
3
3
9
30
44
544
Total Assets
3,160
3,831
4,137
15,015
15,171
16,464
ST Debt & Current Portion LT Debt
501
401
900
2,463
2,754
Accounts Payable
195
261
197
739
933
Income Tax Payable
9
24
27
70
70
Other Current Liabilities
232
316
166
1,439
1,634
Total Current Liabilities
937
1,002
1,289
4,711
5,390
Long-Term Debt
670
1,290
1,067
3,058
1,912
Provision for Risks & Charges
-
22
22
18
14
Deferred Taxes
9
-
5
17
59
Other Liabilities
94
-
27
59
3
Total Liabilities
1,718
2,330
2,420
7,887
7,357
Common Equity (Total)
995
1,167
1,328
5,704
6,173
Total Shareholders' Equity
995
1,167
1,328
5,704
6,173
Total Equity
1,325
1,392
1,612
6,938
7,648
Liabilities & Shareholders' Equity
3,160
3,831
4,137
15,015
15,171
Accumulated Minority Interest
330
225
283
1,235
1,474
Non-Equity Reserves
116
109
106
190
166

About Shanghai Shyndec Pharmaceutical Co.

View Profile
Address
1320 Beijing West Road
Shanghai Shanghai 200040
China
Employees -
Website http://www.shyndec.com
Updated 07/08/2019
Shanghai Shyndec Pharmaceutical Co., Ltd. principally engages in the research, development, manufacturing, and sale of pharmaceutical products. Its product range covers anti-infective drugs, cardiovascular and cerebrovascular drugs, anti-tumour drugs, anaesthetic psychotropic drugs, as well as metabolic and endocrine drugs. The company was founded in 1996 and is headquartered in Shanghai, China.